Novel TARDBP missense mutation caused familial amyotrophic lateral sclerosis with frontotemporal dementia and parkinsonism

Sheng Chen,Rui-Ling Zhou,Wei Zhang,Chun-Hui Che,Shu-Yan Feng,Hua-Pin Huang,Chang-Yun Liu,Zhang-Yu Zou
DOI: https://doi.org/10.1016/j.neurobiolaging.2021.05.017
IF: 5.133
2021-11-01
Neurobiology of Aging
Abstract:<p>Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder that predominately involves the motor neurons in the brain and spinal cord. The <em>TARDBP</em> gene, encoding TAR DNA-binding protein 43 (TDP-43) protein, has been identified as a major causative gene in ALS. In this study, we screened 275 SALS patients and 20 unrelated FALS probands for <em>TARDBP</em> mutations. We identified three <em>TARDBP</em> mutations in three SALS patients and two <em>TARDBP</em> mutations in two FALS probands, including a previously unreported mutation, p.K176I, in FALS patients consistent with frontotemporal dementia (FTD) and parkinsonism. The p.K176I mutation is the first mutation outside exon 6 of the <em>TARDBP</em> gene manifesting parkinsonism and the first <em>TARDBP</em> mutation manifesting parkinsonism identified in the Chinese population. Our results support that <em>TARDBP</em> mutations are one of the most common changes in both FALS and SALS in China. Patients with <em>TARDBP</em> mutations may have a broad phenotype spectrum of ALS, FTD, and parkinsonism. The <em>TARDBP</em> gene should be included in genetic screening for ALS with FTD, and/or parkinsonism.</p>
neurosciences,geriatrics & gerontology,gerontology
What problem does this paper attempt to address?